Work

Sa.75. Susceptibility of Viral Isolates of Pediatric AIDS Clinical Trials Group Protocol 351 to Pro 542 (Rcd4-Igg2) and Pro 140 (Mab to Ccr5)

Year: 2006

Type: article

Source: Clinical Immunology

DOI: 10.1016/j.clim.2006.04.307

Authors: William Shearer, Jaime Deville, Pearl Samson, John MoyeJr., Courtney Fletcher, Joseph Church, Hans Spiegel, Paul Palumbo, Terence Fenton, Elizabeth Smith, Bobbie Graham, Joyce Kraimer, William Olson

Institutions: Baylor College of Medicine, University of California, Los Angeles, Harvard University, National Institutes of Health, University of Colorado Health, University of Colorado Denver, Children's Hospital Los Angeles, Children's National, University of Medicine and Dentistry of New Jersey, National Institute of Allergy and Infectious Diseases, Frontier Science & Technology Research Foundation, Inc., Social and Scientific Systems (United States), Progenics Pharmaceuticals (United States)

Language: English

Topic: HIV Research and Treatment

Subfield: Virology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2071250104

FWCI:

Cites:

Cited by:

Related to: 10